Ferulic acid (4-hydroxy-3-methoxycinnamic acid) is a phenolic compound present in a variety of plants. We recently reported that long-term administration of ferulic acid for 4 weeks protects mice against learning and memory deficits induced by centrally administered b-amyloid (Ab) . 5) In that report, we found that the Ab 1-42 -induced increases in immunoreactivities of glial fibrillary acidic protein (GFAP), the astrocyte marker, and interleukin-1b in the hippocampus are also suppressed by pretreatment with ferulic acid. In the present study, we further characterize the effects of long-term administration of ferulic acid on the activation of microglial cells induced by centrally administered Ab in mice.
MATERIALS AND METHODS

Materials
Male ICR mice weighing 18-26 g at the beginning of experiments (Myung-Jin, Inc., Seoul, Korea) were used in all experiments. The mice were housed 5 per cage in a room maintained at 22Ϯ1°C with an alternating 12-h light-dark cycle. Food was available ad libitum. Ab (American Peptide Company, U.S.A.) and Ab 42-1 (Bachem, Switzerland) were prepared as stock solutions at a concentration of 37 mg/ml in sterile 0.1 M phosphate-buffered saline (PBS) (pH 7.4) and aliquots were stored at Ϫ20°C until use. Ferulic acid (Sigma) was dissolved each day in tap water at a concentration of 0.006% (w/v). Assay with HPLC with electrochemical detection showed 11% loss of ferulic acid (0.006% w/v) in tap water in 24 h at room temperature.
Experimental Design Mice were allowed free access to normal drinking water or ferulic acid solution for 4 weeks. Subsequently, Ab was administered via intracerebroventricular injection, and at various time points after the Ab injection the brains were analyzed immunohistochemically.
Control animals were injected with Ab 42-1 .
Intracerebroventricular Injection of Ab b
1-42
The administration of Ab was performed according to the procedure established by Laursen and Belknap. 6) Briefly, each mouse was injected at the bregma with a 50-ml Hamilton microsyringe fitted with a 26-gauge needle that was inserted to a depth of 2.4 mm. The injection volume was 5 ml.
Immunocytochemistry At various time points after injection of Ab , mice were transcardially perfused and postfixed for 4 h in 4% paraformaldehyde. Brains were cryoprotected in 30% sucrose, sectioned coronally (45 mm) on a freezing microtome, and collected in a cryoprotectant for storage at Ϫ20°C. Floating sections of brains were processed as described previously. 5) After 3 10-min rinses in PBS, sections were placed in the cryoprotectant, preincubated for 30 min in 0.1 M PBS with 1% bovine serum albumin and 0.2% Triton X-100, and incubated overnight with the following primary antisera: anti-rat interferon (IFN)-g (1 : 500, R&D); and anti-rat OX-42 (1 : 500, Harlan SeraLabs). On the following day, the sections were incubated for 1 h in biotinylated rabbit and goat secondary antibody obtained from Vector Laboratories. After incubation with the Vector Elite ABC kit, antigens were detected with 3,3-diaminobenzidine tetrahydrochloride (DAB) as the chromogen.
RESULTS
Inhibition of Ab b
1-42 -Induced Increase in OX-42 Immunoreactivity by Ferulic Acid To examine whether central Ab 1-42 injection induces microglial activation, OX-42 immunoreactivity, a marker of activated microglia, was examined. OX-42 immunoreactivity was markedly enhanced 8 h after injection of Ab (Fig. 1b) , and returned to basal levels at 1 d (data not shown). In animals pretreated with ferulic acid for 4 weeks, the Ab 1-42 -induced increases in hippocampal OX-42 immunoreactivity were effectively blocked (Fig. 1c) .
Inhibition of Key words b-amyloid peptide (Ab); microglia; endothelial nitric oxide synthase; ferulic acid; Alzheimer's disease course of IFN-g immunoreactivity in the hippocampus was the same as OX-42 immunoreactivity. IFN-g-immunoreactive cells appeared to be microglial cells. In animals pretreated with ferulic acid for 4 weeks, the Ab 1-42 -induced increases in hippocampal IFN-g immunoreactivity were effectively blocked (Fig. 1f) .
DISCUSSION
Previously, we reported that a single intracerebroventricular injection of a picomolar dose (410 pmol) of Ab 1-42 in mice effectively activates astrocytes, as evidenced by increased immunoreactivities of GFAP and IL-1b, which were blocked by long-term pretreatment with ferulic acid. 5) In the present study, we extended our previous findings by showing that centrally injected Ab 1-42 induces activation of microglia, as evidenced by the increased immunoreactivity of OX-42, which was also effectively inhibited by ferulic acid.
We found that activation of microglia is more rapid compared with that of astrocytes, i.e., we observed that OX-42 immunoreactivity is increased at 8 h after central injection of Ab , which returned to the basal state at 24 h, while GFAP and eNOS immunoreactivities peaked 3 or 5 d after central Ab 1-42 injection. 5 ) Thus it appears likely that the microglia is activated at 8 h after Ab 1-42 injection, which returns to the basal state 24 h after injection, while astrocyte activation is slower, which peaks post-Ab 1-42 injection day 3 to 5. In addition, activated microglia exhibits increased IFN-g immunoreactivity. The time course of IFN-g immunostaining is the same as that of OX-42. IFN-g could act as an inflammatory amplifier aggravating the neurodegenerative process by priming microglia or monocytes/macrophages for the secretion of proinflammatory cytokines. 7) Further, IFN-g was reported to show a synergistic effect on microglia activation in response to Ab. 8) Although the mechanism of astrocyte activation is unclear at present, it can be speculated that microglia activation induces subsequent astrocyte activation, because the time course of astrocyte activation follows microglia activation. The primary site of action of ferulic acid could be microglia. Thus it may be suggested that long-term administration of ferulic acid could be microglia. Thus it may be suggested that long-term administration of ferulic acid induces microglia to suppress the Ab 1-42 stimulus. Activation of glial cells including increased eNOS expression by preconditioning stimulus was postulated to be responsible for the induction of tolerance to neuronal damage. 5, 9, 10) In our laboratory, we notled a transient and slight increase in IL-1b 5) and eNOS (unpublished data) immunoactivity in astrocytes on day 14 after treatment with ferulic acid, which returned to basal levels on day 28. Thus it can be speculated that activation and subsequent recovery of glial cells by ferulic acid might somehow induce resistance to the subsequent Ab insult to the brain. Further study is needed to explore the exact mechanisms of ferulic acid in neuroprotection against Ab 1-42 . In conclusion, long-term administration of ferulic acid prevented the Ab 1-42 -induced activation of microglia. This inhibition of microglial cell activation may underlie the beneficial effect of long-term administration of ferulic acid against Ab -induced toxicity in vivo. , repectively. Original magnification ϫ20. Scale bar, 25 mm. nϭ6 (6 of 9).
